No abstract available
MeSH terms
-
Administration, Oral
-
Adolescent
-
Antipsychotic Agents / adverse effects*
-
Antipsychotic Agents / therapeutic use
-
Benzodiazepines / adverse effects
-
Benzodiazepines / therapeutic use
-
Chlorpromazine / adverse effects
-
Chlorpromazine / therapeutic use
-
Diagnosis, Differential
-
Dibenzothiazepines / adverse effects*
-
Dibenzothiazepines / therapeutic use
-
Drug Therapy, Combination
-
Humans
-
Injections, Intramuscular
-
Male
-
Neuroleptic Malignant Syndrome / diagnosis*
-
Olanzapine
-
Paranoid Disorders / diagnosis
-
Paranoid Disorders / drug therapy*
-
Paranoid Disorders / psychology
-
Quetiapine Fumarate
Substances
-
Antipsychotic Agents
-
Dibenzothiazepines
-
Benzodiazepines
-
Quetiapine Fumarate
-
Olanzapine
-
Chlorpromazine